The downgrade to Neutral suggests a more cautious outlook on Arvinas' stock by Citigroup, potentially due to valuation or other concerns. However, the significant increase in the price target from $36 to $55 indicates a positive view on the company's fundamentals or growth prospects. This mixed signal could lead to short-term uncertainty among investors, balancing the potential for both positive and negative reactions.